News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
finance.yahoo.com Earnings
Nutanix (NTNX) closed at $66.61 in the latest trading session, marking a -1.98% move from the prior day. The stock's change was less than the S&P 500's daily loss of 0.17%. Meanwhile, the Dow experienced a drop of 0.2%, and the technology-dominated Nasdaq saw a decrease of 0.28%. The enterprise cloud platform services provider's stock has climbed by …
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
In August 2026, Nutanix launched an open-source Model Context Protocol (MCP) server for its Cloud Platform, allowing AI assistants like GitHub Copilot, Claude Code, and Cursor to safely translate plain-English requests into governed infrastructure actions via the Nutanix Prism v4 API. By embedding fine-grained …
Nutanix, Inc. SAN JOSE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a hybrid cloud leader, today announced that it will report its financial results for the fiscal fourth quarter and fiscal year 2026, which ended July 31, 2026, after U.S. …
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Before we discuss the reliability of brokerage …
A concept image of a man holding a box of office supplies after losing his job by chayanuphol via Shutterstock Nutanix (NTNX) stock is in focus on Tuesday after the software company announced layoffs affecting about 5% of its overall headcount. The announcement arrives …
This article reports on a Form 4 filing for Anixa Biosciences Inc. dated August 3. The content itself is very brief, serving primarily as a placeholder to announce the filing and directing readers to further details. The article is published by Investing.com.
Anixa Biosciences Inc. CEO, Amit Kumar, purchased 5,000 shares of common stock at $3.47 per share on July 31, 2026, increasing his direct holdings to 657,000 shares. This open-market transaction was not made under a Rule 10b5-1 plan, and the filing sentiment is positive, …
Anixa Biosciences CEO Amit Kumar purchased 5,000 shares of the company's common stock for $17,350 on July 31, 2026. This transaction occurred after the stock saw a slight decline over the past week but had gained 14% over the past year. Despite the stock …
Anixa Biosciences Inc (NASDAQ:ANIX) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $8.50. The company recently reported a quarterly loss of $0.07 per share, beating analyst expectations. Insider and institutional interest in ANIX has increased, with …
Vanguard Portfolio Management has disclosed a beneficial ownership of 13,440,444 shares of Nutanix Inc. common stock, representing 4.97% of the class as of June 30, 2026. The filing indicates Vanguard has sole voting power over 40,360 shares and sole dispositive power over all 13,440,444 …
Sharemaestro market context Trend signal active 52 weeks -25.4% · Next-week setup negative 28.1%This article provides a risk assessment for Anixa Biosciences Inc (ANIX), noting its current risk score of 2.29, ranking it 222 out of 384 in the Biotechnology & Medical Research industry. The company's beta of 0.61 indicates it tends to underperform during market uptrends …
This article provides a valuation analysis of Anixa Biosciences Inc (ANIX), noting its current valuation score of 8.20 and ranking within the Biotechnology & Medical Research industry. It details the company's current P/E ratio, highlighting its position relative to recent highs and lows. The …
This article lists various Exchange Traded Funds (ETFs) that hold Nutanix, Inc. Class A (NTNX) stocks, presented in a sortable table by market value. It provides key details for each ETF, including issuer, management style, focus, expense ratio, assets under management (AUM), price, change …
This article announces the filing of Form 4 for Anixa Biosciences Inc. on July 29. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in beneficial ownership of a company's stock …
Anixa Biosciences director Arnold M. Baskies exercised 6,000 employee stock options at $3.13 per share on July 27, 2026, which were nearing expiration. To cover the cost, 5,428 shares were withheld by the company at $3.46 per share. Following this transaction, Baskies' direct holdings …
Nutanix (NTNX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the past month, shares of this enterprise cloud …
Anixa Biosciences CEO Amit Kumar purchased 5,000 shares of the company's stock for $17,300, increasing his total holdings to over 640,000 shares. This recent acquisition is part of a pattern of insider buying by Kumar in recent months. Anixa Biosciences (NASDAQ:ANIX) recently traded up …
Anixa Biosciences CEO Amit Kumar recently acquired 5,000 shares of the company's stock for $17,200, increasing his total direct ownership to 652,000 shares. This transaction is part of a series of stock purchases by Kumar, signaling strong insider confidence. The company reported better-than-expected quarterly …
This article details the shareholder structure of Anixa Biosciences Inc (ANIX), listing both major individual and institutional holders as of various recent reporting periods. It provides a breakdown of shareholder types, institutional holdings over several quarters, and recent shareholder activities including changes in stakes …
Anixa Biosciences Inc. CEO Amit Kumar purchased 3,188 shares of common stock at $3.37 per share on July 27, 2026, increasing his direct holdings to 647,000 shares. This transaction, categorized as a purchase in the open market or private transaction, was not executed under …
Anixa Biosciences CEO Amit Kumar recently purchased 3,000 shares of the company's common stock for $11,190, increasing his direct holdings to 643,812 shares. This transaction follows a period of strong stock performance, with the company also making significant advancements in its clinical trials and …
This article reports on a Form 4 filing for Anixa Biosciences Inc. on July 27. It briefly mentions the stock symbol ANIX and its price performance, but provides no further details about the content of the Form 4. The main content of the page …
Anixa Biosciences Inc's CEO, Amit Kumar, purchased 3,000 shares of the company's common stock at $3.73 per share on July 24, 2026. This transaction increased his direct holdings to 643,812 shares. The purchase, valued at $11,000, was an open-market or private transaction and was …
This article analyzes the financial health of Anixa Biosciences Inc (ANIX), noting its weak financial status and low operating efficiency with a financial score of 4.67, ranking 381 out of 386 in its industry. The report highlights that relevant financial data for various metrics …
This article provides a basic overview of Anixa Biosciences, Inc. (NASDAQ: ANIX) financial data as presented on TradingView. It highlights sections for revenue breakdown by source and country, along with general financial stats and market information. The content appears to be a stub or …
Nutanix, Inc. Class A (MUN:0NU) generated a total revenue of €2.22 billion last year, with its Subscription segment being the primary contributor at €2.11 billion. The United States was the largest regional revenue source, accounting for €1.23 billion of the company's total revenue.
This article provides a financial overview of Anixa Biosciences Inc (ANIX), detailing its current stock performance, recent financial indicators, and historical data. It includes a comprehensive breakdown of the company's income statement, balance sheet, and cash flow statement, along with key FAQs regarding its …
Nutanix Inc (NTNX) is a cloud software company providing a single platform for hybrid multicloud infrastructure. The company's stock is currently trading at $66.615, down 1.96% for the day. Analysts rate Nutanix as a "Buy" with a target price of $59.064, and the company …
Search by ticker symbol or company name and select a result to open its chart.